Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameCutia-B
Stock Code02487
Company Full NameTo be extracted
Industry醫療保健
Principal Activities公司是一家專注于皮膚學的研發型生物制藥公司,致力于開發全面的解決方案,以滿足患者及消費者在廣泛皮膚病治療及護理市場中不斷變化的多樣化需求。
Listing Date2023-06-12
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市靜安區恒豐路436號環智國際大廈20樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.cutiatx.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 21.85 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share39.0%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 46,505,540

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 4,370
2 lots 400 HK$ 8,740
3 lots 600 HK$ 13,110
4 lots 800 HK$ 17,480
5 lots 1,000 HK$ 21,850
6 lots 1,200 HK$ 26,220
7 lots 1,400 HK$ 30,590
8 lots 1,600 HK$ 34,960
9 lots 1,800 HK$ 39,330
10 lots 2,000 HK$ 43,700
15 lots 3,000 HK$ 65,550
20 lots 4,000 HK$ 87,400
25 lots 5,000 HK$ 109,250
30 lots 6,000 HK$ 131,100
35 lots 7,000 HK$ 152,950
40 lots 8,000 HK$ 174,800
45 lots 9,000 HK$ 196,650
50 lots 10,000 HK$ 218,500
100 lots 20,000 HK$ 437,000
150 lots 30,000 HK$ 655,500
250 lots 50,000 HK$ 1,092,500
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
5,321 lots 1,064,200 HK$ 23,252,770

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway None
Avg Daily HK Mkt Cap ---
Est. Threshold ---
Analysis Result 无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 21.95
First Day OpenHK$ 21.8
First Day Change-79.95%
First Day Volume1319600.0
First Day Turnover28628000.0
Use of Proceeds
1、約176.7百萬港元(即所得款項凈額的45.0%)將用于我們的核心產品CU-20401; 2、約86.4百萬港元(即所得款項凈額的22.0%)將用于撥付我們主要產品CU-40102及CU-10201的持續研發活動; 3、約70.7百萬港元(即所得款項凈額的18.0%)將用于撥付我們管線中其他候選產品的持續研發活動; 4、約39.3百萬港元(即所得款項凈額的10.0%)乃用于管線擴展的技術開發及業務開發; 5、約19.6百萬港元(即所得款項凈額的5.0%)將用作營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (5)
中国国际金融香港证券有限公司 CE AEN894 Deutsche Bank AG, Hong Kong Branch CE AAK077 CLSA LIMITED CE AAB893 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 招银国际融资有限公司 CE AVM940
Joint Bookrunners (9)
中国国际金融香港证券有限公司 CE AEN894 Deutsche Bank AG, Hong Kong Branch CE AAK077 CLSA LIMITED CE AAB893 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 招银国际融资有限公司 CE AVM940 中银国际亚洲有限公司 CE AET863 UOB KAY HIAN (HONG KONG) LIMITED CE AAW261 富途证券国际(香港)有限公司 CE AZT137 VALUABLE CAPITAL LIMITED CE AUL711
Joint Lead Managers (11)
中国国际金融香港证券有限公司 CE AEN894 Deutsche Bank AG, Hong Kong Branch CE AAK077 CLSA LIMITED CE AAB893 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 招银国际融资有限公司 CE AVM940 中银国际亚洲有限公司 CE AET863 UOB KAY HIAN (HONG KONG) LIMITED CE AAW261 富途证券国际(香港)有限公司 CE AZT137 VALUABLE CAPITAL LIMITED CE AUL711 SILVERBRICKS SECURITIES COMPANY LIMITED CE BLN458 老虎证券(香港)环球有限公司 CE BMU940

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Harvest International Premium Value (Secondary Market) Fund SPC 156,415,410 HKD — 33.64% — 6 months 2023-12-12
2 So-Young Hong Kong Limited 7,817,930 HKD — 1.68% — 6 months 2023-12-12
3 无锡新鸿笛创业投资合伙企业(有限合伙) 17,204,690 HKD — 3.70% — 6 months 2023-12-12

Directors & Management

PositionChinese nameEnglish Name
Chairman陳連勇—
Company Secretary梁志杰—
No director data available.

Major Shareholders

Major Shareholders & Holdings通和毓承實體(49.82%);YF Dermatology Limited(13.16%);SCC Growth V 2020-C, L.P.(11.28%);Fidelity(7.47%)
About this page

This page shows Cutia-B (02487) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect